Right Now
Sign Up
Sign In
Go Prime
Submit Url
Keyword Url
Press Releases
Content Creation Campaigns
Investor Relations
Sign In
Sign Up
Right Now
Right Now
Sign Up
Sign In
Download The Findit App
Share Your Posts On These Major Social Networks
Instatag Your Posts to Instagram Facebook + Twitter
About
Right Now
Pictures
Audio
Followers
Aikido Pharma
Aikido Pharma Inc.
About
Right Now
Pictures
Audio
Followers
Send Message
About
Right Now
Pictures
Audio
Followers
Send Message
Aikido Pharma Has Licensed DHA-dFdC at The University of Texas at Austin
Released On:
05/03/2021
Views:
1080
View
Aikido Pharma Shares Published Papers and Articles on KPC-34 and DHA-dFdC
Released On:
03/03/2021
Views:
1040
View
Aikido Pharma Announces Findings of Positive Results From New Drug “DHA-dFdC” Developed at The University of Texas at Austin
Released On:
01/03/2021
Views:
1081
View
AIkido Pharma Inc. to Present at the H.C. Wainwright Global Life Sciences Conference (Virtual Event)
Released On:
01/03/2021
Views:
1505
View
Meet Aikido Pharma Inc’s Board of Directors
Released On:
28/02/2021
Views:
1124
View
AIkido Pharma Inc. Announces Exercise of Option to Purchase Additional Shares in Bought Deal Offering
Released On:
23/02/2021
Views:
1119
View
Artificial Intelligence Is Optimizing Drug Development
Released On:
22/02/2021
Views:
1150
View
Aikido Pharma Focuses on The Treatment of Four Main Types of Cancer
Released On:
20/02/2021
Views:
1039
View
AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock
Released On:
19/02/2021
Views:
1197
View
AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million
Released On:
16/02/2021
Views:
1281
View
AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock
Released On:
16/02/2021
Views:
1221
View
AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment
Released On:
16/02/2021
Views:
1409
View
Aikido Pharma Announces Information on KPC-34 Which Was Developed at the Wake Forest School of Medicine
Released On:
15/02/2021
Views:
1029
View
Aikido Pharma Establishes Licensing Agreement with University of Maryland for Antiviral Compounds, Including COVID-19
Released On:
10/02/2021
Views:
932
View
Aikido Pharma Announces DHA-dFdC Which Is Licensed From the University of Texas at Austin for the treatment of Pancreatic Cancer.
Released On:
09/02/2021
Views:
1558
View
Aikido Pharma Secures Early Interest in Convergent Therapeutics, Inc. Who Focuses On Next Generation Radiopharmaceutical Therapy for Prostate Cancer
Released On:
05/02/2021
Views:
1115
View
AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board
Released On:
03/02/2021
Views:
2007
View
Meet Aikido Pharma A BioTechnology Development Company Focused on The Treatment Of Early and Mid-Stage Small-Molecule Anti-Cancer Therapeutics
Released On:
03/02/2021
Views:
1226
View
1
2
Map
40.7582826
-73.9788868
Aikido Pharma
Get Directions
Aikido Pharma
One Rockefeller Plaza
New York, New York 10020
United States
(212) 745-1373
×
Message Details
Subject -
From: